SCHEMBL533530

SCHEMBL533530

Cc1cc(C)c(O)c(S(=O)(=O)N(CCN(C)C)c2c(C)cc(C)c(N3CCCCC3)c2C)c1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
MAPT P10636 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
POLB P06746 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KMT2A Q03164 4/20 0.31
MEN1 O00255 3/20 0.31
KDM4E B2RXH2 2/20 0.31
GAA P10253 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
NPC1 O15118 1/20 0.30
LMNA P02545 2/20 0.30
TP53 P04637 1/20 0.30
RXFP1 Q9HBX9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5106673 0.86 ALDH1A1 (0.40) ALDH1A1MAPTSMN1; SMN2POLBHTT
SCHEMBL533087 0.86 ALDH1A1 (0.38) ALDH1A1MAPTSMN1; SMN2POLBHTT
SCHEMBL534072 0.75 ACLY (0.36) ALDH1A1SMN1; SMN2POLBNPSR1KMT2A
SCHEMBL28517649 0.63 ALDH1A1 (0.65) ALDH1A1MAPTSMN1; SMN2POLBHTT
SCHEMBL28831654 0.62 ALDH1A1 (0.51) ALDH1A1MAPTSMN1; SMN2POLBHTT
SCHEMBL15316122 0.61 ALDH1A1 (0.61) ALDH1A1MAPTSMN1; SMN2POLBHTT
SCHEMBL533460 0.61 ALDH1A1 (0.42) ALDH1A1MAPTSMN1; SMN2POLBHTT
SCHEMBL532991 0.60 MAPT (0.47) ALDH1A1MAPTSMN1; SMN2POLBHTT
SCHEMBL6882052 0.58 ALDH1A1 (0.52) ALDH1A1MAPTSMN1; SMN2POLBHTT
SCHEMBL533015 0.58 ACLY (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
WO-2004073634-A2 PHENYLENEDIAMINE UROTENSIN-II RECEPTOR ANTAGONISTS AND CCR-9 ANTAGONISTS ENCYSIVE PHARMACEUTICALS INC. (US) 2004-09-02 WO disclosed